Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masashi Sakaki

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Plos One|May 14, 2013
In vivo intracellular oxygen dynamics in murine brain glioma and immunotherapeutic response of cytotoxic T cells observed by fluorine-19 magnetic resonance imagingJia Zhong, Masashi Sakaki, Hideho Okada, et al.
Journal of Biomedicine & Biotechnology|May 29, 2010
Immune response of cytotoxic T lymphocytes and possibility of vaccine development for hepatitis C virus infectionKazumasa Hiroishi, Junichi Eguchi, Shigeaki Ishii, et al.
Journal of Leukocyte Biology|June 30, 2011
IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in miceKazuyoshi Takeda, Masafumi Nakayama, Masashi Sakaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 21, 2007
Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitisMasashi Sakaki, Kazumasa Hiroishi, Toshiyuki Baba, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 1, 2010
Cyclooxygenase-2 gene promoter polymorphisms affect susceptibility to hepatitis C virus infection and disease progressionMasashi Sakaki, Reiko Makino, Kazumasa Hiroishi, et al.
Clinical and Experimental Nephrology|November 25, 2019
Dotinurad: a clinical pharmacokinetic study of a novel, selective urate reabsorption inhibitor in subjects with hepatic impairmentYuji Kumagai, Masashi Sakaki, Kenichi Furihata, et al.
Journal of Viral Hepatitis|August 7, 2012
Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis CMiyuki Miyashita, Takayoshi Ito, Masashi Sakaki, et al.
Oncoimmunology|July 4, 2012
Differential activity of interferon-α8 promoter is regulated by Oct-1 and a SNP that dictates prognosis of gliomaGary Kohanbash, Eiichi Ishikawa, Mitsugu Fujita, et al.
Oncology Reports|March 20, 2012
Interleukin-4 and CpG oligonucleotide therapy suppresses the outgrowth of tumors by activating tumor-specific Th1-type immune responsesAtsushi Kajiwara, Hiroyoshi Doi, Junichi Eguchi, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 12, 2019
[Primary appendiceal signet ring cell carcinoma:a case report]Yoko Nakajima, Atsushi Kajiwara, Masashi Sakaki, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Plos One|May 14, 2013
In vivo intracellular oxygen dynamics in murine brain glioma and immunotherapeutic response of cytotoxic T cells observed by fluorine-19 magnetic resonance imagingJia Zhong, Masashi Sakaki, Hideho Okada, et al.
Journal of Biomedicine & Biotechnology|May 29, 2010
Immune response of cytotoxic T lymphocytes and possibility of vaccine development for hepatitis C virus infectionKazumasa Hiroishi, Junichi Eguchi, Shigeaki Ishii, et al.
Journal of Leukocyte Biology|June 30, 2011
IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in miceKazuyoshi Takeda, Masafumi Nakayama, Masashi Sakaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 21, 2007
Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitisMasashi Sakaki, Kazumasa Hiroishi, Toshiyuki Baba, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 1, 2010
Cyclooxygenase-2 gene promoter polymorphisms affect susceptibility to hepatitis C virus infection and disease progressionMasashi Sakaki, Reiko Makino, Kazumasa Hiroishi, et al.
Clinical and Experimental Nephrology|November 25, 2019
Dotinurad: a clinical pharmacokinetic study of a novel, selective urate reabsorption inhibitor in subjects with hepatic impairmentYuji Kumagai, Masashi Sakaki, Kenichi Furihata, et al.
Journal of Viral Hepatitis|August 7, 2012
Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis CMiyuki Miyashita, Takayoshi Ito, Masashi Sakaki, et al.
Oncoimmunology|July 4, 2012
Differential activity of interferon-α8 promoter is regulated by Oct-1 and a SNP that dictates prognosis of gliomaGary Kohanbash, Eiichi Ishikawa, Mitsugu Fujita, et al.
Oncology Reports|March 20, 2012
Interleukin-4 and CpG oligonucleotide therapy suppresses the outgrowth of tumors by activating tumor-specific Th1-type immune responsesAtsushi Kajiwara, Hiroyoshi Doi, Junichi Eguchi, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 12, 2019
[Primary appendiceal signet ring cell carcinoma:a case report]Yoko Nakajima, Atsushi Kajiwara, Masashi Sakaki, et al.
Pageof 4